TABLE 2.
Artificial neural network evaluation of the impact of virtual lisdexamfetamine over comorbidities.
| Depression | Anxiety | Bipolar disorder | Binge eating disorder | Tic disorder | |
| vLDX | Very high (94%) | Medium (76%) | Low (17%) | Very high (94%) | Medium (71%) |
Categories: very high (score [100–92], p-value < 0.01); high (score [92–77], p-value < 0.05); medium (score [77–37], p-value < 0.25); low (score < 37, p-value ≥ 0.25). vLDX, virtual lisdexamfetamine.